CortControl
Medical Food Formulations
616223894.jpg

blog

CortControl Blog

CortControl Received U.S. Patent for Fertility Enhancement Medical Food

BY JAMES DANIELS, CEO, CORTCONTROL LLC

Recently, we at CortControl received some excellent news that we hope will soon be life-changing news for many couples experiencing infertility-related issues. The Directory of the U.S. Patent and Trademark Office has officially granted our company a patent for our fertility enhancement medical food Glutrasol IF™.

Glutrasol IF treats infertility in both men and women that may result from high cortisol levels due to increased stress: a condition, which, according to Colette Bopuchez of WebMD, “may actually play a role in up to 30% of all infertility problems.” And, although Glutrasol IF is a relatively new product, it is based on chemistries that veterinarians have—for more than 40 years—found to be highly effective in increasing fertility rates in cattle and other livestock. In some cases, these fertility rates have increased by as much as 70%.

While there are numerous infertility treatments on the market, Glutrasol IF offers two distinctive benefits that both fertility specialists and patients will find extremely attractive. First, since Glutrasol IF is a medical food that is ingested just like other foods, it is non-invasive. And second, as a medical food, it is far less expensive than in vitro fertilization and other fertility treatments that can cost many thousands of dollars. For these reasons, and because of its proven effectiveness with livestock, we believe that Glutrasol IF can be a sensible, low-cost initial treatment that effectively addresses infertility for many couples before specialists turn to more invasive and costly approaches.

For pharmaceutical companies and others interested in partnering with CortControl in the actual mass production, marketing, and distribution of Glutrasol IF, an enormous opportunity also exists. According to the Mayo Clinic, between 10% and 15% of all couples of childbearing age have difficulty either conceiving or taking a pregnancy through to term. In the U.S. alone, this represents tens of millions of couples—many of them potential Glutrasol IF users.

The vast majority of people look at having children as one of life’s great experiences. Sadly, though, problems with infertility create major challenges for a significant number of them. Glutasol IF, of course, is only one of numerous treatment options people have when considering infertility solutions. But, for everyone with a stake in infertility treatment, it is also quite innovative and absolutely worth investigating.

Jim Daniels is the CEO and Co-founder of CortControl, an LLC that develops and markets the

medical foods Glutrasol IF for infertility and Glutrasol VE for vaccine enhancement. For more information about medical foods in general or Glutrasol IF in particular, please visit www.cortcontrol.com or contact Jim directly at Jim@cortcontrol.com.

 

Laura CoxComment